Triumeq ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	3

2. 筋萎縮性側索硬化症

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05193994 (ClinicalTrials.gov)	February 24, 2022	6/12/2021	Triumeq in Amyotrophic Lateral Sclerosis	Randomised Double-Blind Placebo-Controlled Phase 3 Trial of Triumeq in Amyotrophic Lateral Sclerosis	Amyotrophic Lateral Sclerosis	Drug: Dolutegravir, Abacavir and Lamivudine;Drug: Placebo	Macquarie University, Australia	King's College London;Stichting TRICALS Foundation	Recruiting	18 Years	N/A	All	390	Phase 3	Australia
2	EUCTR2020-005069-15-NL (EUCTR)	23/06/2021	14/04/2021	LIGHTHOUSE 2	RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 3 TRIAL OF TRIUMEQIN AMYOTROPHIC LATERAL SCLEROSIS ...	Amyotrophic Lateral Sclerosis (ALS) MedDRA version: 21.1;Level: PT;Classification code 10002026;Term ...	Trade Name: Triumeq Product Name: Triumeq INN or Proposed INN: Dolutegravir INN or Proposed INN: Abacav ...	Stichting TRICALS Foundation	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	390	Phase 3	Australia;Netherlands;United Kingdom
3	NCT02868580 (ClinicalTrials.gov)	October 2016	16/6/2016	Safety and Tolerability of Antiretroviral (Triumeq) in Patients With Amyotrophic Lateral Sclerosis ( ...	Phase 2a Open Label Study, Safety and Tolerability of Combination Antiretroviral Therapy (Triumeq) i ...	Amyotrophic Lateral Sclerosis	Drug: Triumeq	Neuroscience Trials Australia	Macquarie University, Australia;Westmead Hosptial;Calvary Health Care Bethlehem;The University of Sy ...	Completed	18 Years	75 Years	All	43	Phase 2	Australia

First Previous1Next Last